CC slider pharma web

Acquisition Search #2961i

Pharmaceutical Company with strong infrastructure for prescription drugs in Europe

Our clients, the owners of a multinational pharmaceutical company with over 70 years of experience are now looking to grow their business in Europe.

Our clients are actively engaged in various manufacturing and trading activities in the fields of pharmaceuticals, life science and various consumer products, but most importantly they are committed to ground-breaking research, development and marketing, seeking to ensure quality products are made available to people within Europe and beyond, to contribute to a better standard of health and a more comfortable life for all.

Their current pharmaceutical business is focused on:

Prescription Based Medication
OTC, Consumer Healthcare, Dietary Supplements
Medical Equipment

At this stage, our clients would like to expand their market reach and are particularly keen in exploring business opportunities in the pharmaceutical sector specialised in distribution and production of Rx type medication.

The ideal acquisition target should have the following attributes:

Infrastructure for prescription drugs
Distribution network in place
Diverse product base portfolio (Rx, OTC and Medical Devices)
Products in the Therapeutic Area, Lifestyle-related diseases and Ophthalmology

Established 2nd tier management in place able to run the business on a day to day basis
Proven long-term sustainability with consistent profitability year on year
Development Pipeline

Both listed and non-listed companies are of interest.

Our clients are highly motivated and keen to progress quickly on an acquisition once the right opportunity is identified.

Key Information

Primary business activity Pharmaceutical

Acquisition Budget Price up to £200M

Location EU member states (Austria, Germany, Spain, France, Portugal, Greece, etc.), UK excluded

Re-locatable Flexible

Existing Staff Retention Yes



Request an introduction